Literature DB >> 7764258

Isolation, characterization, and transmission of human T-lymphotropic virus types I and II in culture.

K Kitamura1, D L Rudolph, C Goldsmith, T M Folks, R B Lal.   

Abstract

Highly sensitive coculture methods were developed both for isolation of human T-lymphotropic virus types I and II (HTLV-1 and HTLV-II) from infected individuals and for productive infection of lymphoid cells. Mitogen-activated peripheral blood mononuclear cells (PBMC) from 13 HTLV-I- and 20 HTLV-II-positive specimens were cocultured with an equal number of mitogen-activated PBMC from HTLV-seronegative individuals, and culture supernatants were tested for the presence of soluble p24gag antigens at weekly intervals for 4 weeks. Eleven of 13 (85%) HTLV-I and 14 of 20 (70%) HTLV-II cultures were positive for p24 antigens. None of the 17 HTLV-seroindeterminate or six HTLV-seronegative specimens were positive for the presence of p24 antigen. The isolation rates for HTLV-I and HTLV-II by an alternative whole-blood lysis procedure were comparable to those obtained by standard PBMC cultures. Furthermore, cocultivation of PHA-stimulated PBMC from healthy donors with lethally irradiated HTLV-I- and HTLV-II-infected cell lines (SP and Mo-T, respectively) resulted in productive viral infection, as reflected by the appearance of p24gag antigens concomitant with specific genomic amplification of HTLV proviral DNA after 3 weeks of cocultivation. Thus, the cocultivation technique provides a highly sensitive and specific procedure both for HTLV isolation and for infection of target cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7764258     DOI: 10.1007/BF01568960

Source DB:  PubMed          Journal:  Curr Microbiol        ISSN: 0343-8651            Impact factor:   2.188


  27 in total

1.  Primary isolation of human T-cell leukemia-lymphoma virus types I and II: use for confirming infection in seroindeterminate blood donors.

Authors:  B Hjelle; R Mills; C Goldsmith; S G Swenson; S Cyrus
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

2.  Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections in HTLV-I/II-seropositive individuals.

Authors:  W Heneine; R F Khabbaz; R B Lal; J E Kaplan
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

Review 3.  The epidemiology of the human T-cell lymphotrophic virus type I and type II: etiologic role in human disease.

Authors:  A Manns; W A Blattner
Journal:  Transfusion       Date:  1991-01       Impact factor: 3.157

4.  Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV.

Authors:  T Folks; J Kelly; S Benn; A Kinter; J Justement; J Gold; R Redfield; K W Sell; A S Fauci
Journal:  J Immunol       Date:  1986-06-01       Impact factor: 5.422

5.  Expression of HTLV-I antigen in cultured peripheral blood mononuclear cells from patients with HTLV-I associated myelopathy.

Authors:  S Minato; Y Itoyama; I Goto; N Yamamoto
Journal:  J Neurol Sci       Date:  1988-11       Impact factor: 3.181

6.  Constitutive production of interleukin-6 and tumor necrosis factor-alpha from spontaneously proliferating T cells in patients with human T-cell lymphotropic virus type-I/II.

Authors:  R B Lal; D L Rudolph
Journal:  Blood       Date:  1991-08-01       Impact factor: 22.113

7.  In situ hybridization detection of HTLV-I RNA in peripheral blood mononuclear cells of TSP/HAM patients and their spouses.

Authors:  M A Beilke; D R In; M Gravell; R S Hamilton; C A Mora; M Leon-Monzon; P E Rodgers-Johnson; D C Gajdusek; C J Gibbs; V Zaninovic
Journal:  J Med Virol       Date:  1991-01       Impact factor: 2.327

8.  Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line.

Authors:  N Yamamoto; M Okada; Y Koyanagi; M Kannagi; Y Hinuma
Journal:  Science       Date:  1982-08-20       Impact factor: 47.728

9.  Expression of ICAM-1 (CD54) on normal and leukaemic B cells: implication for the mixed lymphocyte reaction.

Authors:  M R Padros; M I Noli; L Fainboim
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

10.  Human T-lymphotropic virus type I screening in volunteer blood donors--United States, 1989.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1990-12-21       Impact factor: 17.586

View more
  1 in total

1.  Inhibitors of strand transfer that prevent integration and inhibit human T-cell leukemia virus type 1 early replication.

Authors:  Samira Rabaaoui; Fatima Zouhiri; Agnès Lançon; Hervé Leh; Jean d'Angelo; Eric Wattel
Journal:  Antimicrob Agents Chemother       Date:  2008-03-03       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.